Seeking efficiency in executive compensation benchmarking?

Unlock Efficiency in Executive Compensation Benchmarking with CompAnalyst Executive

CompAnalyst Executive

The charts on this page feature a breakdown of the total annual pay for the top executives at SILK ROAD MEDICAL INC as reported in their proxy statements.

Total Cash Compensation information is comprised of yearly Base Pay and Bonuses. SILK ROAD MEDICAL INC income statements for executive base pay and bonus are filed yearly with the SEC in the edgar filing system. SILK ROAD MEDICAL INC annual reports of executive compensation and pay are most commonly found in the Def 14a documents.

Total Equity aggregates grant date fair value of stock and option awards and long term incentives granted during the fiscal year.

Other Compensation covers all compensation-like awards that don't fit in any of these other standard categories. Numbers reported do not include change in pension value and non-qualified deferred compensation earnings.

Name And Title Total Cash Equity Other Total Compensation
Lucas W. Buchanan
Chief Operating Officer and Chief Financial Officer
Total Cash $849,743 Equity $8,688,516 Other $20,809 Total Compensation $9,559,068
Andrew S. Davis
Chief Commercial Officer
Total Cash $803,896 Equity $7,061,596 Other $32,430 Total Compensation $7,897,922
Erica J. Rogers
President, Chief Executive Officer and Director
Total Cash $1,150,667 Equity $14,110,692 Other $15,714 Total Compensation $15,277,073
Richard M. Ruedy
Executive Vice President of Regulatory Affairs, Clinical Affairs and Quality Assurance
Total Cash $533,260 Equity $958,728 Other $9,150 Total Compensation $1,501,138
Kevin M. Klemz
Executive Vice President, Chief Legal Officer and Secretary
Total Cash $368,100 Equity $1,999,992 Other $8,415 Total Compensation $2,376,507
For its 2022 fiscal year, SILK ROAD MEDICAL INC, listed the following CEO pay ratio data on its annual proxy statement to the SEC.
CEO Name CEO Pay Median Employee Pay CEO Pay Ratio
Erica J. Rogers CEO Pay $15,277,073 Median Employee Pay $176,552 CEO Pay Ratio 87:1
For its 2022 fiscal year, SILK ROAD MEDICAL INC, listed the following board members on its annual proxy statement to the SEC.
Name Total COMPENSATION
Donald J. Zurbay Total Cash $192,967
Elizabeth H. Weatherman Total Cash $174,967
Jack W. Lasersohn Total Cash $226,800
Kevin J. Ballinger Total Cash $184,634
Rick D. Anderson Total Cash $184,967
Tanisha V. Carino, Ph.D. Total Cash $166,290
Tony M. Chou, M.D. Total Cash $164,967

This report is not for commercial use. Thorough reviews have been conducted to assure this data accurately reflects disclosures. However for a complete and definitive understanding of the pay practices of any company, users should refer directly to the actual, complete proxy statement.

The information shown here is a reporting of information included in the company's proxy statement. The proxy statement includes footnotes and explanations of this information plus other information that is pertinent in assessing the overall value and appropriateness of the compensation information. For those interested in conducting a detailed compensation analysis, we recommend that you review the entire proxy statement. You may retrieve the full proxy statement by going to the Securities and Exchange Commission (SEC) website at www.sec.gov and entering the company's name and then looking in the first column for an entry of "Form DEF 14A" (or any similar code). You may also find the annual proxy statement by going directly to the company's website.

A proxy statement (or "proxy") is a form that every publicly traded U.S. company is required to file with the U.S. Securities & Exchange Commission (SEC) within 120 days after the end of its fiscal year. The proxy must be sent to every shareholder in advance of the company's annual shareholders meeting. All proxy statements are public filings made available to the general public by the SEC.

The proxy statement's main purpose is to alert shareholders to the annual meeting and provide them information about the issues that will be voted on during the annual meeting, including decisions such as electing directors, ratifying the selection of auditors, and other shareholder-related decisions, including shareholder-initiated initiatives. Also, proxies must disclose specific detailed information regarding the pay practices for certain executives.